Is Lantheus Holdings, Inc. overvalued or undervalued?

As of 17 October 2025, Lantheus Holdings, Inc. has moved from a fair to attractive valuation grade, indicating a shift towards being undervalued. The company appears to be undervalued based on its current P/E ratio of 15, significantly lower than the peer average of 24.20 for QIAGEN NV, which is considered fair. Additionally, Lantheus has an EV to EBITDA ratio of 10.33 compared to the industry average, suggesting it is trading at a more favorable valuation relative to its earnings potential.
In terms of performance metrics, Lantheus boasts a remarkable ROCE of 56.47% and an ROE of 31.84%, reflecting strong operational efficiency and profitability. When compared to its peers, Dentsply Sirona, Inc. has a P/E of 9.91, indicating that Lantheus is positioned competitively in the market. Despite recent challenges, the stock has outperformed the S&P 500 over the past week and month, with returns of 3.85% and 9.36%, respectively, although it has struggled year-to-date and over the past year. Overall, the valuation metrics and peer comparisons suggest that Lantheus Holdings, Inc. is currently undervalued.